May 17, 2020

Merck and Samsung BioLogics to further their partnership

Catherine Sturman
2 min
Udit Batra, Merck CEO, Life Science & Dr. Tae-Han Kim, President & CEO, Samsung BioLogics.
In the growing biopharmaceutical market, manufacturers are moving toward end-to-end solutions — from process development and scale-up through to manuf...

In the growing biopharmaceutical market, manufacturers are moving toward end-to-end solutions — from process development and scale-up through to manufacturing for pre-clinical, clinical and commercial supply — as they seek to cut costs while increasing quality and efficiency.

Leading science and technology company Merck has therefore signed an MoU with Samsung BioLogics to further its biopharmaceutical manufacturing and biologics process development capabilities. It acts as an extension to the MoU the companies signed back in 2014.

Samsung BioLogics is a global full-service provider of quality-driven contract process development and cGMP manufacturing to the global biopharmaceutical industry. The alliance will see the duo further grow its process development and clinical material production at small biotech start-ups focusing on novel drug development for which Samsung BioLogics acts as a contract manufacturer.

“Merck's process development expertise and Mobius, the wide single-use bioprocessing portfolio, will allow innovations to reach patients faster," commented Udit Batra, Member of the Merck Executive Board and CEO, Life Science.

Related stories

The company remains a premier supplier of process development and clinical-stage manufacturing solutions, materials and services needed to produce biopharmaceutical drugs and is committed to delivering superior bioreactor technology to manufacturers worldwide.

Samsung’s one-stop services include cell line generation, process and analytical method development, analytical services, clinical and commercial bulk cGMP manufacturing of drug substance and drug product. This also includes quality assurance, quality control, regulatory compliance standards and support for its customers.

Merck has been the key solution provider for Samsung BioLogics' 30KL facility and 152KL facility in Korea, and has trained Samsung BioLogics team on building a robust biologics development process.

"This alliance will create synergy and maximize our technology potential," stated Dr. Tae-Han Kim, President and CEO of Samsung BioLogics.

Share article

Jun 14, 2021

Zoom enters the healthcare market - a timeline

telehealth
videoconsultations
covid-19
Zoom
3 min
We chart Zoom's rise and entrance into the healthcare market

Since the pandemic began Zoom has become an integral part of daily life for people working from home, as well as a vital tool for families and friends to communicate. However it's also been eyeing up the healthcare space since 2017, and following the boom in telehealth the company has been rolling out additional services. Here we chart Zoom's move into healthcare. 

2011 - 2013


Zoom is founded in San Jose, California, by Eric Yuan, formerly of Cisco. He got the idea to create a video calling platform from his visits to his girlfriend while he was a student, which would take 10 hours by train. 

A beta version is released in 2012, which can host up to 15 participants. In 2013 this rises to 25. By mid-2013, Zoom has 1 million users. 

2014 - 2017

Zoom attracts investors, including Sequoia Capital, Emergence and Horizon Ventures. By January 2017, Zoom has a series D funding worth $100 million.

2017 - 2019

Zoom for Telehealth launches, including an integration with EHR system Epic. It has cloud-based video, audio, and content sharing features, a "waiting room" for patients, and can easily be integrated into healthcare provider's workflows. 

In 2019 Zoom goes public, with its IPO rising 72% in one day. 

2020

As a result of the pandemic, Zoom gains 2.2 million new users, more than in the whole of 2019. On the 23rd of March alone - the day the UK lockdown was announced - the platform was downloaded 2.13 million times around the world. 

Share prices rise to around $150, and founder and chief executive Eric Yuan becomes one of the world's richest people, with an estimated net worth of $7.9 billion. 

Early security issues are addressed by encrypting data with the Advanced Encryption Standard (AES). By now the the platform allows 99 people to be on a call simultaneously
New features launch, including Zoom Home and Zoom for Chats. Throughout the year the platform is used to replace most kinds of real life events: work meetings, online classrooms, church services and social events. 

2021

Renamed Zoom for Healthcare, users can share secured video, audio, and content through desktops, mobile phones, and conference devices. As well as Epic, it can be integrated with Strmr, IntakeQ, and Practice Better.

It can also be used with diagnostic cameras and other point-of-care devices, including digital stethoscopes.

In an interview with Korea Biomedical Review, Zoom Global Healthcare Lead Ron Emerson said: "Our service is not simply a virtual care and telemedicine platform but a multi-purpose platform that can satisfy the needs of healthcare institutions."

"It can be used for administrative tasks, including telemedicine, medical team meetings, recruitment, medical education, employee training, and disease prevention. Analysing electronic records managed by Zoom could provide meaningful insights into patient care." 

Phoenix Children's Hospital, Belfast's Hospital Services Limited, Butler Health Services and the global Project ECHO are among Zoom for Healthcare's current customers. 

Share article